EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Tumor-mediated remote regulation of peripheral blood platelets

Ruohao Wu, Yuping Li, Xin Li, Ruiling Zu, Peiyin Zhang, Xingmei Zhang, Lubei Rao, Dongsheng Wang, Qun Yi, Tian Li, Ping Leng, Huaichao Luo

Cell Biology and Toxicology · 20.12.2025 · 42 (1)

DOI: 10.1007/s10565-025-10133-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell Biology and Toxicology, online erschienen am 20.12.2025. Verfasst von Ruohao Wu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Chongqing Key Laboratory of Sichuan-Chongqing Co-Construction for Diagnosisand, Treatment of Infectious Diseases Integrated Traditional Chinese and W…. Hauptthemen laut MEDLINE: Blood Platelets, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The role of platelets in blood coagulation and vascular repair is well known. In recent years, extensive attention has been given to the fact that the impact of tumors on peripheral blood platelets plays a key role in cancer progression. This review systematically summarizes the latest research progress on how tumors regulate the quantity, volume, composition, and activation status of peripheral blood platelets through multiple mechanisms. First, tumor cells can induce excessive platelet production by activating AhR-RUNX1 signaling through paracrine pathways and the release of kynurenine, thereby leading to thrombocytosis, which is associated with advanced tumor stages, metastasis, and poor prognosis. Second, tumor progression may trigger disseminated intravascular coagulation (DIC) or chemotherapy-related bone marrow suppression, which in turn results in consumptive thrombocytopenia. In addition, dynamic changes in the mean platelet volume (MPV) are related to tumor type and progression stage, which may reflect abnormal megakaryocyte differentiation or inflammatory status. In terms of platelet composition, tumor cells can remodel the proteome and transcriptome of platelets by secreting ADP, IgG, and functional RNA. Changes in RNA profiles have been confirmed to have potential for tumor diagnosis. In terms of activation status, tumor cells can induce platelet activation and aggregation (TCIPA) by releasing procoagulant factors such as tissue factors and exosomes (EVs), accelerating thrombosis and promoting angiogenesis. In clinical applications, platelet-related biomarkers have become a research hotspot for early cancer diagnosis and prognostic evaluation. Moreover, targeting platelets affected by tumors provides new strategies for tumor treatment. On the basis of the scientific findings of numerous existing studies, it is speculated that there seems to be a "dynamic balance" among platelets, which also provides a new direction for future research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood PlateletsNeoplasmsHumansAnimalsPlatelet ActivationSignal TransductionThrombocytosis

Stichwörter der Autor:innen

Liquid biopsyPlateletThrombocytosisTumor

Autor:innen und Institutionen

  • Chongqing Key Laboratory of Sichuan-Chongqing Co-Construction for Diagnosisand, Treatment of Infectious Diseases Integrated Traditional Chinese and Western Medicine, College of Medical Technology , Chengdu University of…
  • Department of Clinical Laboratory, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology o…
  • Department of Critical Care Medicine, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China.
  • Tianjin Key Laboratory of Acute Abdomen Disease-Associated Organ Injury and ITCWM Repair, Institute of Integrative Medicine of Acute Abdominal Diseases, Tianjin Nankai Hospital, Tianjin Medical University, 8 Changjiang…

Zitieren

APA

Wu, R., Li, Y., Li, X., Zu, R., Zhang, P., Zhang, X., Rao, L., Wang, D., Yi, Q., Li, T., Leng, P., & Luo, H. (2025). Tumor-mediated remote regulation of peripheral blood platelets. Cell Biology and Toxicology, 42(1). https://doi.org/10.1007/s10565-025-10133-4

Vancouver

Wu R, Li Y, Li X, Zu R, Zhang P, Zhang X, et al. Tumor-mediated remote regulation of peripheral blood platelets. Cell Biology and Toxicology. 2025;42(1). doi:10.1007/s10565-025-10133-4

BibTeX
@article{Wu2025,
  author = {Wu, Ruohao and Li, Yuping and Li, Xin and Zu, Ruiling and Zhang, Peiyin and Zhang, Xingmei and Rao, Lubei and Wang, Dongsheng and Yi, Qun and Li, Tian and Leng, Ping and Luo, Huaichao},
  title = {Tumor-mediated remote regulation of peripheral blood platelets},
  journal = {Cell Biology and Toxicology},
  year = {2025},
  volume = {42},
  number = {1},
  doi = {10.1007/s10565-025-10133-4}
}
Kostenlos starten →